FAIRFIELD, Conn., Sept. 21, 2011 (GLOBE NEWSWIRE) -- Competitive Technologies, Inc. (OTCQX:CTTC) today announced that it has signed two new international distribution agreements that have resulted in immediate orders for Calmare® Scrambler Therapy™ medical devices. The new distributors are Ahsan Anaesthetist Ltd., which will be responsible for sales in Ireland, and the Mediterranean for Technology & Trading SAL Offshore (MTT- Elyssa Holding), which will be responsible for sales in sixteen countries in the Middle East and North Africa.
"We are pleased to see the increased utilization of the Calmare Scrambler Therapy device internationally," said Umberto Marangoni, CTTC's Managing Director of International Business Development. "We believe these agreements and a number of others we are currently negotiating in additional countries are a reflection of the increased worldwide interest in our non-invasive pain therapy which is free of harmful side effects."
About Competitive Technologies, Inc
Competitive Technologies is a global leader in developing and commercializing innovative products and technologies. CTTC is multifaceted, providing distribution, patent and technology transfer, sales and licensing services. CTTC's staff is focused on the needs of customers and matching those requirements with commercially viable products or technology solutions.
CTTC is the licensed worldwide distributor of the non-invasive Calmare® pain therapy medical device, which incorporates the biophysical "Scrambler Therapy™" technology developed in Italy by CTTC's client, Professor Giuseppe Marineo to treat neuropathic pain, including cancer pain. The Calmare® device is currently being manufactured for sale by CTTC's partner, GEOMC Co., Ltd. of Seoul, Korea. For more information on the device, visit www.calmarett.com. Visit CTTC's website: www.competitivetech.net.
Statements made about our future expectations are forward-looking statements and subject to risks and uncertainties as described in our most recent Annual Report on Form 10-K for the year ended July 31, 2010, filed with the SEC on October 27, 2010, and other filings with the SEC, and are subject to change at any time. Our actual results could differ materially from these forward-looking statements. We undertake no obligation to update publicly any forward-looking statement.